BRPI0712168A2 - veìculo de expressão de multigenes, vetor de expressão de veìculo de expressão de multigenes, célula de planta, planta trnsgênica, vetor de transformação de planta, métodos de expressar concorrentemente duas a oito proteìnas e de expressar concorrentemente 3 a 8 protéinas em uma célula de planta - Google Patents

veìculo de expressão de multigenes, vetor de expressão de veìculo de expressão de multigenes, célula de planta, planta trnsgênica, vetor de transformação de planta, métodos de expressar concorrentemente duas a oito proteìnas e de expressar concorrentemente 3 a 8 protéinas em uma célula de planta

Info

Publication number
BRPI0712168A2
BRPI0712168A2 BRPI0712168-7A BRPI0712168A BRPI0712168A2 BR PI0712168 A2 BRPI0712168 A2 BR PI0712168A2 BR PI0712168 A BRPI0712168 A BR PI0712168A BR PI0712168 A2 BRPI0712168 A2 BR PI0712168A2
Authority
BR
Brazil
Prior art keywords
multigen
plant
proteins
expression vehicle
expression
Prior art date
Application number
BRPI0712168-7A
Other languages
English (en)
Inventor
Marilyn Anne Anderson
Robyn Louise Heath
Original Assignee
Hexima Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexima Ltd filed Critical Hexima Ltd
Publication of BRPI0712168A2 publication Critical patent/BRPI0712168A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Insects & Arthropods (AREA)
  • Pest Control & Pesticides (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

VEìCULO DE EXPRESSãO DE MULTIGENES, VETOR DE EXPRESSãO DE VEìCULO DE EXPRESSãO DE MULTIGENES, CéLULA DE PLANTA, PLANTA TRANSGêNICA, VETOR DE TRANSFORMAçãO DE PLANTA, MéTODOS DE EXPRESSAR CONCORRENTEMENTE DUAS A OITO PROTEìNAS, E DE EXPRESSAR CONCORRENTEMENTE 3 A 8 PROTEìNAS EM UMA CéLULA DE PLANTA. Um veículo de expressão de multigenes (MGEV) consistindo essencialmente de um polinucleotídeo compreendendo 2 a 8 segmentos de domínio, D, cada domínio codificando uma proteína funcional, cada domínio sendo unido no seguinte em uma seqílóncia linear por um segmento Ligador (L) codificando um peptideo Ligador, os segmentos D e L estando todos na mesma matriz de leitura, e pelo menos um dos domínios não é um inibidor de protease de tipo dois.
BRPI0712168-7A 2006-05-25 2007-05-24 veìculo de expressão de multigenes, vetor de expressão de veìculo de expressão de multigenes, célula de planta, planta trnsgênica, vetor de transformação de planta, métodos de expressar concorrentemente duas a oito proteìnas e de expressar concorrentemente 3 a 8 protéinas em uma célula de planta BRPI0712168A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80320606P 2006-05-25 2006-05-25
PCT/AU2007/000712 WO2007137329A2 (en) 2006-05-25 2007-05-24 Multi-gene expression vehicle

Publications (1)

Publication Number Publication Date
BRPI0712168A2 true BRPI0712168A2 (pt) 2012-03-13

Family

ID=38779010

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0712168-7A BRPI0712168A2 (pt) 2006-05-25 2007-05-24 veìculo de expressão de multigenes, vetor de expressão de veìculo de expressão de multigenes, célula de planta, planta trnsgênica, vetor de transformação de planta, métodos de expressar concorrentemente duas a oito proteìnas e de expressar concorrentemente 3 a 8 protéinas em uma célula de planta

Country Status (12)

Country Link
US (2) US20070277263A1 (pt)
EP (1) EP2027264B1 (pt)
JP (1) JP2009537155A (pt)
CN (1) CN101517077B (pt)
AR (1) AR063166A1 (pt)
AU (1) AU2007266307C1 (pt)
BR (1) BRPI0712168A2 (pt)
CA (1) CA2653404C (pt)
NZ (1) NZ572795A (pt)
SG (1) SG171689A1 (pt)
WO (1) WO2007137329A2 (pt)
ZA (1) ZA200809722B (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE510015T1 (de) 2001-02-08 2011-06-15 Hexima Ltd Aus pflanzen stammende moleküle und diese codierende genetische sequenzen sowie verwendungen dafür
US20090083880A1 (en) * 2007-04-20 2009-03-26 Hexima Ltd. Modified plant defensin
AR075257A1 (es) * 2008-02-01 2011-03-23 Hexima Ltd Sistema de proteccion de plantas contra la infeccion por agentes patogenos
US9889184B2 (en) 2008-08-05 2018-02-13 Hexima Limited Anti-pathogen systems
US20100095408A1 (en) * 2008-08-05 2010-04-15 Hexima Limited Anti-Pathogen Systems
CA2825118C (en) 2011-02-07 2020-02-18 Hexima Limited Modified plant defensins useful as anti-pathogenic agents
WO2013078433A1 (en) 2011-11-23 2013-05-30 University Of Hawaii Auto-processing domains for polypeptide expression
US11692016B2 (en) 2012-03-09 2023-07-04 Vestaron Corporation High gene expression yeast strain
NZ727213A (en) 2012-03-09 2020-03-27 Vestaron Corp Toxic peptide production, peptide expression in plants and combinations of cysteine rich peptides
JP6457945B2 (ja) * 2012-11-23 2019-01-23 ヘキシマ リミテッドＨｅｘｉｍａ Ｌｉｍｉｔｅｄ 抗病原体方法
CN103114102B (zh) * 2013-01-29 2014-12-03 华南农业大学 一种多基因载体组装方法与应用
CA2901316A1 (en) 2013-03-15 2014-09-25 Pioneer Hi-Bred International, Inc. Phi-4 polypeptides and methods for their use
BR112016003225B1 (pt) 2013-08-16 2022-10-25 Pioneer Hi-Bred International, Inc. Polipeptídeo pip-47, polipeptídeo pip-47 quimérico, composição, proteína de fusão, método para controlar uma população de inseto-praga, método para inibir o crescimento ou matar um inseto-praga, construto de dna, polinucleotídeo isolado, cassete de expressão, método de obtenção de uma planta transgênica e método para controlar infestação de inseto
BR122020001770B1 (pt) 2013-09-13 2022-11-29 Pioneer Hi-Bred International, Inc Construto de dna, método de obtenção de planta transgênica, proteína de fusão, método para controlar uma população de praga de inseto, método para inibir o crescimento ou matar uma praga de inseto
BR112016018103B1 (pt) 2014-02-07 2024-01-16 E.I. Du Pont De Nemours And Company Polipeptídeo e seu uso, polinucleotídeo, composição, proteína de fusão, método para controlar uma população, método para inibir o crescimento, método para controlar a infestação, método para obtenção de uma planta ou célula vegetal, construto
CN106536545B (zh) 2014-02-07 2026-03-03 先锋国际良种公司 杀昆虫蛋白及其使用方法
CN113372421B (zh) 2014-10-16 2024-08-06 先锋国际良种公司 杀昆虫蛋白及其使用方法
CN114075267B (zh) 2015-01-15 2025-03-18 先锋国际良种公司 杀昆虫蛋白及其使用方法
CA2985198A1 (en) 2015-05-19 2016-11-24 Pioneer Hi-Bred International, Inc. Insecticidal proteins and methods for their use
BR112018002535A2 (pt) 2015-08-06 2018-09-25 Du Pont polipeptídeo inseticida recombinante, polinucleotídeo recombinante, construto de dna, planta transgênica ou célula de planta, composição, proteína de fusão, método para controlar uma praga, método para inibir crescimento ou para exterminar uma população de pragas ou uma praga e uso do polipeptídeo
CN108575091A (zh) 2015-12-18 2018-09-25 先锋国际良种公司 杀昆虫蛋白及其使用方法
AR107854A1 (es) * 2016-03-11 2018-06-13 Donald Danforth Plant Science Center Proteínas defensina multiméricas y métodos relacionados
CA3018384A1 (en) 2016-05-04 2017-11-09 Pioneer Hi-Bred International, Inc. Insecticidal proteins and methods for their use
EP3478052B1 (en) 2016-07-01 2021-08-25 Pioneer Hi-Bred International, Inc. Insecticidal proteins from plants and methods for their use
BR112019008023A2 (pt) 2016-10-21 2019-07-09 Vestaron Corp peptídeo, proteína inseticida e/ou nematicida, polinucleotídeo, vetor, célula hospedeira, constructo de dna, planta, ou parte da mesma, e, método de controle de uma infecção por peste de uma planta.
EP3535285B1 (en) 2016-11-01 2022-04-06 Pioneer Hi-Bred International, Inc. Insecticidal proteins and methods for their use
BR112019012339A2 (pt) 2016-12-14 2019-11-26 Pioneer Hi Bred Int polipeptídeo inseticida recombinante, composição, construto de dna, célula hospedeira, planta transgênica, método para inibir o crescimento ou extermínio de uma praga de inseto ou população de praga, polipeptídeo ipd093 quimérico e proteína de fusão
US11213028B2 (en) 2016-12-22 2022-01-04 Pioneer Hi-Bred International, Inc. Insecticidal proteins and methods for their use
WO2018148001A1 (en) 2017-02-08 2018-08-16 Pioneer Hi-Bred International Inc Insecticidal combinations of plant derived insecticidal proteins and methods for their use
RU2019140646A (ru) 2017-05-11 2021-06-11 Пайонир Хай-Бред Интернэшнл, Инк. Инсектицидные белки и способы их применения
CA3092078A1 (en) 2018-03-14 2019-09-19 Pioneer Hi-Bred International, Inc. Insecticidal proteins from plants and methods for their use
AU2019234562B2 (en) 2018-03-14 2024-08-01 Pioneer Hi-Bred International, Inc. Insecticidal proteins from plants and methods for their use
WO2020046701A1 (en) 2018-08-29 2020-03-05 Pioneer Hi-Bred International, Inc. Insecticidal proteins and methods for their use
CN110157710B (zh) * 2019-07-11 2022-12-27 贵州大学 花烟草NaD1基因启动子及其用途
BR112022027035A2 (pt) 2020-07-14 2023-04-11 Pioneer Hi Bred Int Proteínas inseticidas e métodos para uso das mesmas
CN117448304B (zh) * 2023-10-19 2025-11-04 安徽科宝生物工程有限公司 一种葡萄糖醛酸酶及其突变体和在胆红素生产中的应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5100792A (en) * 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
WO1992015691A1 (en) * 1991-03-11 1992-09-17 Imperial Chemical Industries Plc Biocidal proteins
US5446127A (en) * 1991-05-24 1995-08-29 Universidad Politecnica De Madrid Antipathogenic peptides and compositions containing the same
US5538525A (en) * 1991-08-29 1996-07-23 Zeneca Limited Biocidal proteins
ATE291624T1 (de) * 1992-12-16 2005-04-15 Hexima Ltd Ein proteinase inhibitor, vorläufer davon und genetische sequenzen dafür kodierend
EP0712413A1 (en) * 1993-08-04 1996-05-22 Zeneca Limited Antimicrobial proteins
CA2205356A1 (en) * 1994-11-21 1996-05-30 Peter Edward Urwin Modified proteinase inhibitors
US6605698B1 (en) * 1995-12-13 2003-08-12 Syngenta Limited Antifungal peptides and composition thereof
US6909032B2 (en) * 1996-01-31 2005-06-21 Commonwealth Scientific And Industrial Research Organisation DNA encoding a macadamia integrifolia anti-microbial protein, constructs comprising the same and plant material comprising the constructs
US5773696A (en) * 1996-03-29 1998-06-30 Monsanto Company Antifungal polypeptide and methods for controlling plant pathogenic fungi
US6121436A (en) * 1996-12-13 2000-09-19 Monsanto Company Antifungal polypeptide and methods for controlling plant pathogenic fungi
AUPO427596A0 (en) * 1996-12-20 1997-01-23 Cooperative Research Centre For Tropical Plant Pathology Anti-microbial protein
GB9725556D0 (en) * 1997-12-03 1998-02-04 Ciba Geigy Ag Organic compounds
CN1315999A (zh) * 1998-08-18 2001-10-03 曾尼卡有限公司 在植物中表达多蛋白的遗传学方法
US6855865B2 (en) * 1999-05-07 2005-02-15 E.I. Du Pont De Nemours And Company Nucleic acids encoding plant defensins and methods of use thereof
US6677503B1 (en) * 1999-06-23 2004-01-13 Pioneer Hi-Bred International, Inc. Sunflower anti-pathogene proteins and genes and their uses
US6770750B2 (en) * 1999-11-18 2004-08-03 Korea Kumho Petrochemical Co., Ltd. Small and cysteine rich antifungal defensin and thionin-like protein genes highly expressed in the incompatible interaction
US20020059658A1 (en) * 2000-06-15 2002-05-16 Zhong-Min Wei Methods of improving the effectiveness of transgenic plants
US7141723B2 (en) * 2001-01-29 2006-11-28 Cargill, Incorporated Transgenic plants resistant to Sclerotinia and Phoma lingam
ATE510015T1 (de) * 2001-02-08 2011-06-15 Hexima Ltd Aus pflanzen stammende moleküle und diese codierende genetische sequenzen sowie verwendungen dafür
WO2003000863A2 (en) * 2001-06-22 2003-01-03 Pioneer Hi-Bred International, Inc. Defensin polynucleotides and methods of use
CN100406190C (zh) * 2001-11-02 2008-07-30 波音公司 形成具有残余压应力分布形式的焊接接头的装置和方法
CA2521940C (en) 2003-04-23 2010-01-26 Latrobe University Insect chymotrypsin and inhibitors thereof
US20070197474A1 (en) * 2004-03-30 2007-08-23 Clinton William P Methods for controlling plants pathogens using N-phosphonomethylglycine
US20090083880A1 (en) * 2007-04-20 2009-03-26 Hexima Ltd. Modified plant defensin

Also Published As

Publication number Publication date
US20070277263A1 (en) 2007-11-29
CN101517077B (zh) 2014-04-16
US20140259231A1 (en) 2014-09-11
JP2009537155A (ja) 2009-10-29
WO2007137329A3 (en) 2009-06-18
AR063166A1 (es) 2008-12-30
EP2027264B1 (en) 2014-10-29
CA2653404A1 (en) 2007-12-06
AU2007266307A1 (en) 2007-12-06
AU2007266307B2 (en) 2012-05-31
CN101517077A (zh) 2009-08-26
WO2007137329A2 (en) 2007-12-06
AU2007266307C1 (en) 2012-10-25
EP2027264A4 (en) 2010-02-03
EP2027264A2 (en) 2009-02-25
WO2007137329A9 (en) 2009-01-22
NZ572795A (en) 2011-06-30
SG171689A1 (en) 2011-06-29
CA2653404C (en) 2015-06-30
ZA200809722B (en) 2009-11-25

Similar Documents

Publication Publication Date Title
BRPI0712168A2 (pt) veìculo de expressão de multigenes, vetor de expressão de veìculo de expressão de multigenes, célula de planta, planta trnsgênica, vetor de transformação de planta, métodos de expressar concorrentemente duas a oito proteìnas e de expressar concorrentemente 3 a 8 protéinas em uma célula de planta
BRPI0616824B8 (pt) peptídeo quimérico, seu uso, composição farmacêutica compreendendo o mesmo, e kit
AR064216A1 (es) Polipeptidos cristalinos de bacillus thuringiensis, polinucleotidos y composiciones de los mismos
AR049214A1 (es) Peptidos de transito a plastidos
UY31123A1 (es) Proteinas de fusion natriureticas
AR068894A1 (es) Proteinas delta- endotoxina axmi-066 y axmi-076 y metodos de uso de las mismas
ATE416190T1 (de) Polypeptide mit bindungsaffinität für her2
BR112013010487A2 (pt) novos substratos de coelenterazina e métodos de uso
BR112018075363A2 (pt) neurotoxinas botulínicas manipuladas
AR061491A1 (es) Una familia de proteinas pesticidas y metodos de uso de las mismas
BRPI0715718A2 (pt) Anticorpo, métodos de triar para um anticorpo para o domínio extracelular de uma proteína prlr, de alterar sistematicamente anticorpos e triar para um anticorpo para o domínio extracelular de uma proteína prlr, de tratar um indivíduo que sofre de câncer, de alvejar uma célula tumoral que expressa prlr, de usar uma célula hospedeira, de identificar um indivíduo com necessidade de tratamento com um anticorpo anti-prlr, e de monitorar terapia de câncer em um indivíduo, molécula de ácido nucleico isolada, vetor de expressão, célula hospedeira, composição farmacêutica, e, kit
CO6690759A2 (es) Anticuerpos, fragmentos de unión o derivados de los mismos que se unen específicamente a la proteína 4-1 bb
AR061467A1 (es) Axmi-031 axmi-039 axmi-040 y axmi-049 una familia de nuevos genes de delta-endotoxinas y metodos para usarlos
HRP20220531T1 (hr) Varijabilni fragmenti antitijela koji se umeću i modificirane a1-a2 domene nkg2d liganda
AR074032A1 (es) Polipeptidos de eritropoietina modificados y usos de los mismos.
AR082502A1 (es) Proteinas osteogenicas de diseño
CL2011001285A1 (es) Anticuerpo que se une a la angiopoyetina-2 humana (ang-2 o ang2 o angpt2); acido nucleico que lo codifica; vector de expresion recombinante; celula huesped; composicion farmaceutica que lo comprende; y su uso para tratar cancer.
AR067672A1 (es) Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas
BR112015005389A2 (pt) composições e sistemas para conferir resistência a doença em plantas e métodos de uso das mesmas
EA201491494A1 (ru) Нацеливание на гликаны хондроитинсульфаты
AR025984A1 (es) Polipeptidos oligomericos de cadena simple
BRPI0614761A2 (pt) proteìnas de fusão de albumina
BRPI0907621A2 (pt) utilização de peptídeos de trânsito para plastídios provenientes de glaucófitas
BR112012006501A8 (pt) Polipeptídios e usos dos mesmos
EA201170263A1 (ru) Гены, белки и векторы для повышения устойчивости растений и микроорганизмов к абиотическим стрессам и их применение

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: HEXIMA LIMITED (AU)

B25G Requested change of headquarter approved

Owner name: HEXIMA LIMITED (AU)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 15A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2672 DE 22-03-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.